...
首页> 外文期刊>Acta biomaterialia >Scalable MSC-derived bone tissue modules: In vitro assessment of differentiation, matrix deposition, and compressive load bearing
【24h】

Scalable MSC-derived bone tissue modules: In vitro assessment of differentiation, matrix deposition, and compressive load bearing

机译:可扩展的MSC衍生的骨组织模块:分化,基质沉积和压缩载荷的体外评估

获取原文
获取原文并翻译 | 示例

摘要

Enhancements to the mechanical properties of modular designs for bone tissue engineering could increase their clinical applications. In this study, bone marrow mesenchymal stem cells (MSCs) and hydroxyapatite (HAP) microgranules were encapsulated in polyelectrolyte complex membranes composed of chondroitin 4-sulfate (C4S), carboxymethyl cellulose (CMC) and chitosan. Microcapsules were formed with and without HAP microgranules, and cultured in either osteoinduction medium (Osteo) or expansion medium (Exp) to produce four microcapsule conditions: Osteo, Osteo+HAP, Exp, and Exp +HAP. Microcapsules facilitated alkaline phosphatase secretion and deposition of bone specific proteins (osteocalcin and osteopontin) by encapsulated MSCs over 28 days of osteogenic culture. SEM and micro-CT analysis showed cell-deposited mineral covering the surfaces of the HAP microgranules and interior of the microcapsule membrane. The mineralized microcapsules could be combined and fused into cylindrical constructs (4 x 5 mm, W x H), and uniaxial compression tests confirmed that microcapsule mineralization greatly enhanced the yield stresses of Osteo and Osteo+HAP fused constructs (10.4 +/- 4.4 MPa and 6.4 +/- 2.8 MPa), compared to only HAP microgranules (Exp+HAP, 0.5 +/- 0.3 MPa). The C4S/C/Chitosan microcapsules provide a platform allowing pre-mineralization of microcapsules in vitro for later assembly of larger load-bearing constructs, or for use as an injectable bone regeneration strategy.
机译:对骨组织工程模块化设计的力学性能的增强可以增加其临床应用。在该研究中,骨髓间充质干细胞(MSCs)和羟基磷灰石(HAP)微粒包封在由软骨素4-硫酸酯(C4s),羧甲基纤维素(CMC)和壳聚糖组成的聚电解质复合膜中。用HAP微粒形成微胶囊,并在骨诱导培养基(Osteo)或膨胀介质(EXP)中培养以产生四种微胶囊条件:Osteo,Osteo + Hap,Exp和Exp + Hap。微胶囊促进碱性磷酸酶分泌并通过包封的MSCs在成骨培养物的28天内通过包封的MSC沉积骨特异性蛋白质(骨钙蛋白和骨桥蛋白)。 SEM和Micro-CT分析显示细胞沉积的矿物覆盖HAP微粒的表面和微胶囊膜的内部。可以将矿化微胶囊组合并融合到圆柱形构建体中(4×5mm,W×H),并且单轴压缩试验证实微胶囊矿化大大提高了骨酮和骨酮+ Hap融合构建体的产屈服应力(10.4 +/- 4.4MPa和6.4 +/- 2.8MPa),仅与HAP MicroGranules(EXP + HAP,0.5 +/- 0.3 MPa)相比。 C4s / C /壳聚糖微胶囊提供了一种平台,允许在体外进行微胶囊的预矿化,以便更高组装较大的承载构建体,或用作可注射骨再生策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号